Trials / Completed
CompletedNCT00197821
Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 611 (actual)
- Sponsor
- Public Health England · Other Government
- Sex
- All
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
To compare the relative immunogenicity and reactogenicity of the existing 23 valent plain pneumococcal vaccine and a 7 valent pneumococcal conjugate vaccine in healthy UK adults aged 50-80 years, and subsequent antibody persistence and response to boosting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | pneumococcal conjugate vaccine | Pneumococcal conjugate vaccine |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2005-09-20
- Last updated
- 2012-03-28
Source: ClinicalTrials.gov record NCT00197821. Inclusion in this directory is not an endorsement.